Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients.

导出 OA

翻译打印收藏纠错

作者： Mauro,Gori ^[1] ; Carlo,Berzuini ^[2] ; Emilia,D'Elia ^[1] ; Arianna,Ghirardi ^[1] ; Luisa,Bernardinelli ^[3] ; Antonello,Gavazzi ^[4] ; Giulio,Balestrieri ^[1] ; Andrea,Giammarresi ^[1] ; Roberto,Trevisan ^[5] ; Fabiano,Di Marco ^[6] ; Antonio,Bellasi ^[7] ; Mariangela,Amoroso ^[8] ; Federico,Raimondi ^[8] ; Luca,Novelli ^[8] ; Bianca,Magro ^[9] ; Gianpaolo,Mangia ^[9] ; Ferdinando L,Lorini ^[10] ; Giulio,Guagliumi ^[1] ; Stefano,Fagiuoli ^[9] ; Gianfranco,Parati ^[11] ; Michele,Senni ^[1]

作者单位： Cardiovascular Department, Bergamo, Italy. ^[1] ASST Papa Giovanni XXIII, Bergamo, Italy.;Centre for Biostatistics, School of Health Sciences, The University of Manchester, Manchester, UK. ^[2] The Department of Brain and Behavioural Sciences, The University of Pavia, Pavia, Italy. ^[3] FROM Research Foundation, Bergamo, Italy. ^[4] The Endocrinology Unit, Bergamo, Italy. ^[5] The Unit of Pulmonary Medicine, Bergamo, Italy.;University of Milan. ^[6] The Department of Research, Innovation, Brand Reputation, Bergamo, Italy. ^[7] The Unit of Pulmonary Medicine, Bergamo, Italy. ^[8] The Gastroenterology Hepatology and Transplantation Unit, Bergamo, Italy. ^[9] The Intensive Care Unit, Bergamo, Italy. ^[10] Istituto Auxologico Italiano, IRCCS, Department of Cardiovascular, Neural and Metabolic Sciences, S. Luca Hospital.;Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy. ^[11]